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ABSTRACT The interaction of bovine factor V. with phosphatidylcholine membranes was examined using four different
fluorescence techniques: 1) changes in the fluorescence anisotropy of the fluorescent membrane probe 1,6-diphenyl-1,3,5-
hexatriene (DPH) to monitor the interaction of factor Va with 1,2-dimyristoyl-3-sn-phosphatidylcholine (DMPC) small unila-
mellar vesicles (SUVs), 2) changes in the fluorescence anisotropy of N-(lissamine rhodamine B sulfonyl) diacyl phosphati-
dylethanolamine (Rh-PE) incorporated into SUVs prepared from 1 -palmitoyl-2-oleoyl-3-sn-phosphatidylcholine (POPC), 3)
changes in the fluorescence anisotropy of fluorescein-labeled factor Va (labeled in the heavy chain) upon interaction with
POPC SUVs, 4) fluorescence energy transfer from fluorescein-labeled factor Va to rhodamine-labeled POPC SUVs. In the first
two sets of experiments, labeled lipid vesicles were titrated with unlabeled protein, whereas, in the latter two types of
experiments, labeled factor V, was titrated with vesicles. For the weak binding observed here, it was impossible from any one
binding experiment to obtain precise estimates of the three parameters involved in modeling the lipid-protein interaction,
namely, the dissociation constant Kd, the stoichiometry of binding i, and the saturation value of the observable Rma, from any
one experiment. However, a global analysis of the four data sets involving POPC SUVs yielded a stable estimate of the binding
parameters (Kd of 3.0 ,uM and a stoichiometry of 200 lipids per bound factor Va). Binding to DMPC SUVs may be of
slightly higher affinity. These observations support the contention that association of factor Va with a membrane involves a
significant acidic-lipid-independent interaction along with the more commonly accepted acidic-lipid-dependent component
of the total binding free energy.
INTRODUCTION
Factor Va is a non-enzymatic cofactor that combines with
the serine protease factor Xa on a platelet or phospholipid
membrane in the presence of calcium ions to form the
prothrombinase complex. Prothrombinase complex cata-
lyzes the activation of prothrombin to thrombin in the
coagulation cascade. Factor Va is a heterodimer composed
of a heavy chain derived from the NH2-terminal part of
factor V (Mr = 94,000) and a light chain (Mr of either
74,000 or 71,000) derived from the COOH-terminal end of
the factor V molecule (Kane and Majerus, 1981; Suzuki et
al., 1982; Nesheim et al., 1984). These two chains are
noncovalently associated (Esmon, 1979; Nesheim and
Mann, 1979) to form a fully active factor Va in solution by
the addition of divalent metal ions (Krishnaswamy et al.,
1989). Membrane binding is also commonly seen as involv-
ing only the light chain subunit of factor Va (Krishnaswamy
and Mann, 1988; Kalafatis et al., 1994). This subunit is
reported to bind to the platelet surface or phospholipid
vesicle independently of the amino-terminal-derived heavy
chain (Tracy and Mann, 1983; Krishnaswamy and Mann,
1988).
The requirement for negatively charged phospholipids for
interaction of factor Va with procoagulant membranes is
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generally accepted, despite the fact that the interaction has
recently been argued to involve both hydrophobic and elec-
trostatic interactions (Kalafatis et al., 1990; Ortel et al.,
1992; Lecompte et al., 1994). However, Kalafatis et al.
(1994) have recently observed photoactivated labeling of
factor Va in the presence of membranes containing only
neutral phospholipid, implying an interaction with a neutral
phospholipid membrane. We also report in a companion
paper (Cutsforth et al.,_ 1996) that binding of factor Va to
membranes is a complex process involving both acidic-
lipid-independent and acidic-lipid-dependent interactions,
apparently linked by conformational changes in the protein.
In this study, we have monitored the binding of factor Va
to membranes composed of only phosphatidylcholine by
employing four different fluorescence methods. Because
this binding is weak, we discuss why it is difficult to study
it under conditions that lead to stable estimates of binding
parameters. However, global analysis of data from four
different experiments indicates that factor Va binds to small
unilamellar vesicles (SUVs) with a dissociation constant of
-3.0 ,uM and a binding stoichiometry of -200 lipids per
bound factor Va.
MATERIALS AND METHODS
Materials
1,2-Dimyristoyl-3-sn-phospatidylcholine (DMPC), N-(lissamine rhoda-
mine B sulfonyl) diacyl phosphatidylethanolamine (Rh-PE), and sodium
salts of bovine phosphatidylserine (PS) and POPC were purchased from
Avanti Polar Lipids (Birmingham, AL) and shown to be greater than 98%
pure by thin-layer chromatography (Lentz et al., 1982). All of the lipids
were stocked in argon-bubbled chloroform with or without a small amount
of methanol. Solvents were low residue, HPLC grade. Calcium ion con-
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tamination of the acidic lipids was shown to be less than 2 mol % (Lentz
et al., 1982). 1,6-Diphenyl-1,3,5,-hexatriene (DPH) was purchased from
Molecular Probes (Junction City, OR). All other chemicals were reagent
grade or better. Phospholipid vesicles were prepared as described in the
accompanying paper (Cutsforth et al., 1996) in a buffer containing 20 mM
N-[tris(hydroxymethyl)methyl]-2-aminoethanesulfonic acid (TES), 150
mM NaCl, pH 7.4. Total phosphate concentration in a vesicle sample was
determined using the method of Chen et al. (1956).
Modification of factor Va heavy chain with
fluorescein maleimide
Bovine factor V purified by the procedure of Esmon (1979) was activated
by addition of 10 U of bovine a-thrombin per ml of factor V (1-2 mg/ml
bovine factor V). It was then purified on a Mono S HR 5/5 ion-exchange
column (Pharmacia, Norwalk, CT) coupled to a Perkin-Elmer Isopure LC
system (Perkin-Elmer Corp., Norwalk, CT). The activity of isolated factor
Va was evaluated by the thromboplastin assay in terms of the clotting time
of factor-V-deficient plasma standardized against the clotting time of
pooled, normal human plasma (Nesheim et al., 1981). The heavy and light
chain components of factor Va were separated by ion-exchange on QAE-
Sepharose (Pharmacia Corp., Piscataway, NJ; Esmon, 1979). The light
chain was further purified by HPLC on a Mono S column (Pharmacia
Corp.; Odegaard and Mann, 1987). The heavy chain component was found
to contain a large amount of 55,000-mol wt protein, which was removed on
a Biogel-100 gel filtration column (Bio-Rad Laboratories, Richmond, CA).
The heavy chain was finally purified on a Mono Q HR 5/5 ion-exchange
column (Pharmacia Corp.) coupled to a Perkin-Elmer Isopure LC system.
The final purity of the factor Va components was ascertained by sodium
dodecyl sulfate polyacrylamide gel electrophoresis (Wycoff et al., 1977)
using the Bio-Rad Minigel system to be greater than 85%.
To prepare labeled factor Va, a 6-,ul aliquot of a stock solution of
fluorescein-5-maleimide (Molecular Probes; 51 mM in N,N-dimethylfor-
mamide) was added to 100 ,ul of buffer (20 mM TES, 150 mM NaCl, 5
mM CaCl2, pH 7.4) and mixed well. Factor Va heavy chain (600 ,ul) in 20
mM TES, 150 mM NaCl, 5 mM CaCl2, pH 7.4 (5.8 mg/ml stock), was
treated with this probe solution by slowly adding the probe solution with
constant mixing. The mixture was then incubated in the dark at 4°C for 18
h and then passed through a Sephacryl S-100-HR column (50 x 1 cm inner
diameter) at 4°C equilibrated with 20 mM TES, 150 mM NaCl, 5 mM
CaCl2, pH 7.4. Fractions containing factor Va heavy chain were pooled on
the basis of the absorbance values at 280 nm and precipitated by the
addition of solid ammonium sulfate (80% saturation), collected by centrif-
ugation (50,000 X g for 20 min), resuspended in 20 mM TES, 5 mM
CaCl2, 50% (v/v) glycerol, pH 7.4, and stored at -20°C. Protein concen-
tration was determined by the bicinchonic acid assay (Pierce Chemical Co.,
Rockford, IL), and the molar ratio of fluorescein to protein (0.95) was
determined using the molar absorptivity of protein-conjugated fluorescein
at 494 nm (e = 64,800 M-1 cm-'; Molecular Probes). Factor Va was
reconstituted using fluorescein-labeled heavy chain and unlabeled light
chain in a molar ratio of 1.2:1 in a buffer composed of 20 mM TES, 150
mM NaCl, 5 mM CaCl2, pH 7.5. Purity of the fluorescein-labeled factor Va
heavy chain and reconstituted factor Va was established on the basis of
sodium dodecyl sulfate polyacrylamide gel electrophoresis. The protein
was determined to be more than 85% pure based on densitometry analysis
of the gel, and fluorescence was detected only from the band corresponding
to the factor Va heavy chain, indicating that the fluorescence being mon-
itored was due only to the factor Va heavy chain.
Activity of reconstituted factor Va used for the experiments was eval-
uated by measuring prothrombin activation catalyzed by prothrombinase
using the fluorescent a-thrombin inhibitor dansylarginine-N-(3-ethyl-1,
5-pentanediyl)amide (Nesheim et al., 1981). The functional factor Va
concentration was found to be more than 90% of the concentration deter-
Fluorescence measurements
All fluorescence measurements were made using an SLM 48,000 spec-
trofluorometer (SLM Aminco, Urbana, IL). All fluorescence anisotropy
measurements were carried out as described in Cutsforth et al. (1996).
For the measurements with fluorescein-labeled factor Va, an excitation
wavelength of 490 nm was used. Excitation slits were 8 and 4 nm,
respectively, and 500-nm cutoff filters were used in the emission path.
Measurements were carried out at 23°C. Aliquots of SUVs were added to
the cuvette containing the labeled Va in 20mM TES, 150mM NaCl, 5 mM
CaC12, pH 7.5. The sample was stirred for 2 min after each addition and the
readings were taken 45 s after the stirring was stopped. Correction for the
light scatter of vesicles was made by measuring and subtracting from
observed values the parallel and perpendicular components of intensity due
to vesicles alone.
Measurement of DPH fluorescence anisotropy was carried out by add-
ing a small volume (-1.5 ,ul) of a stock solution of DPH (0.332 mM) in
acetone to DMPC SUV suspensions to achieve a final dye:lipid ratio of
1:150. The vesicles were vortexed thoroughly and incubated for 1 h before
use to achieve maximal partitioning of DPH into the bilayer (Lentz et al.,
1976). DPH-containing vesicles were added to a stirred microcuvette
containing buffer (20 mM TES, 150 mM NaCl, 5.5 mM CaCl2, pH 7.4).
The final concentration of the phospholipid was 0.015 mM. Aliquots of
factor Va (12 ,uM) in 20 mM TES, 150 mM NaCl, S mM CaC12, pH 7.5,
were then successively added to the cuvette. These measurements were
carried out at 30°C so that the lipid was maintained in its fluid phase. An
excitation wavelength of 366 nm was used, with excitation slits of 4 and 8
nm, respectively, and 418-nm cutoff filters were used in the emission paths
in the T format.
Rhodamine fluorescence anisotropy measurements with POPC/Rh-PE
(99/1) SUVs were done by adding aliquots of factor Va to a cuvette
(maintained at 23°C) containing vesicle suspensions (200 ,uM) in 20 mM
TES, 150 mM NaCl, 5 mM CaCl2, pH 7.5. An excitation wavelength of
540 nm was used, with excitation slits of 8 and 4 nm, respectively, and
550-nm cutoff filters in the emission paths in the T format. After each
addition of the protein, the cuvette contents were subsequently stirred for
2 min, with measurements taken approximately 45 s after stirring was
stopped. A background contribution was subtracted from the parallel
component of the total fluorescence to correct for light scattering due to the
high concentrations of SUVs and factor Va used in these experiments.
For the fluorescence energy transfer measurements, excitation was at
470 nm, and the excitation slits were 8 and 4 nm. Emission was recorded
at 520 nm for the donor and 590 nm for the acceptor. The emission slits
were 4 and 8 nm. Aliquots of SUVs of POPC containing 1% Rh-PE were
added to a microcuvette containing fluorescein-labeled factor Va in 20 mM
TES, 150 mM NaCl, S mM CaCl2, pH 7.5. The cuvette contents (main-
tained at 23°C) were constantly stirred, and after an equilibration time of
2 min, emission was recorded. For measurements based on fluorescence
intensity, corrections were made for the fluorophore (donor) dilution by
addition of unlabeled vesicles to the donor, and corrections were also done
for acceptor fluorescence by measuring the fluorescence intensity of the
acceptor alone at the donor excitation wavelength. The absorbance of the
sample containing the highest concentration of Rh-PEIPOPC (1/99) SUVs
was -0.03, meaning that inner filter effects on fluorescence measurements
should be minimal. Even if significant, this contribution would be propor-
tional to lipid concentration and would thus be included in the slope of the
binding curve at high concentrations of the phospholipid (see Eq. 6).
Analysis of individual binding data sets
Individual binding data sets were analyzed using a Marquardt-Levenberg
weighted, nonlinear least squares algorithm supplied with Sigma Plot
(v 1.02; Jandel Scientific, Corte Madera, CA). Weighting assumed errors in
observables are proportional to the observable. This algorithm was used to
assign values for the binding parameters by obtaining the best fit of
calculated to observed adsorption isotherms. Two basic types of experi-
mined from molar absorptivity measurements.
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factor Va was carried out. In these cases, a reporter group was included in
the vesicles and an observable response (R) was recorded as a function of
the total concentration of protein added ([PIT). The essential assumption is
that the response is related to the fraction of phospholipid sites bound to
protein:
[PL]b Robs-Ro
[PL]tot Rmax-R0(-1 )
With this assumption, binding can be analyzed in terms of a classical
Langmuir independent sites adsorption model. Positive (protein-protein
attractions) and negative (protein crowding or protein-protein repulsions)
deviations from this behavior were judged not to be significant in the case
of acidic-lipid-containing membranes (Cutsforth et al., 1996; Cutsforth,
1991). The observable response at any concentration of added protein can
then be expressed in terms of the site dissociation constant for the binding
reaction (Kd) and the concentration of free protein [P]f:
Robs-Ro_ [P]f (2
Rmax -Ro [P]f + Kd
In this equation, we assume binding of protein to multiple, equivalent, and
non-interacting surface sites, each containing 1/i phospholipids. Robs is the
observed response due to the binding of protein to the lipid surface, Rmax
is the observed response when all of the lipid sites are occupied by protein,
and Ro is the observed response before addition of any protein. The
observed response in the binding reaction can be expressed as a function of
the total protein concentration ([PIT) using the following equation:
(Rmax - Ro)/[P]TKdRobs = Ro + .+ [PLT + Kd2[PL]T 1 1/
(Rmax - Ro) [P (4([P]TT [PL]T))
2[PL}~. i -PL T I
(3)
The value of Rmax can be fixed directly from the titration curve only if
sufficient protein can be added to reach clear saturation. In the two
experiments reported here that fall into this category, R was the fluores-
cence anisotropy (r) of DPH or of Rh-PE, and rmax could not be determined
directly.
In the second type of experiment, lipid vesicles are added to labeled
protein and the observed response is taken as representing the fraction of
protein bound:
[P]b Robs RO (4)
[P]T Rm -ROR
The observed response is described in terms of the total concentration of
phospholipid added ([PLIT) in terms of the following equation:
+ (Rmax - Ro)Robs R 2[PT
([PL]Ti + [P]T + Kd)- 2[PT(-)
(1([P]T + [PL]Ti + Kd)2 - (4([P]T * [PL1T) i))
The same three parameters describe the binding reaction as in Eq. 3. In the
first of two experiments of this class described here, R is the fluorescence
anisotropy of fluorescein-labeled factor Va and Eq. 5 becomes that given
by Krishnaswamy et al. (1986) to describe binding of pyrene-labeled factor
Va. In this case, corrections were made for light-scattering contributions by
addition of vesicles to buffer alone.
Experiments reported here involving fluorescence energy transfer mea-
surements represent a special case of this type of experiment. In this case,
Robs is the ratio of donor (fluorescein factor Va) fluorescence efficiency in
the absence and presence of acceptor (rhodamine-labeled lipid vesicles;
FdlFd.). The observed response is still proportional to [Plb, which is still
given by Eq. 5. However, there is a complication unique to the resonance
energy transfer method in that FdIFda continues to increase in a linear
fashion even after binding is saturated simply due to the increase in the
probability of transfer associated with higher acceptor concentration. This
linear dependence on acceptor concentration is predicted for a solution of
non-interacting donor and acceptor molecules (Forster, 1959). The data
were thus fit with the following equation:
Fd
Fda [l- +)]M PL]T/max
-1
(6)
where the first term accounts for binding, with [P]d[PIT given by Eq. 5,
and the second term accounts for transfer between acceptor and donor that
are not bound to each other. The parameter values, Kd, i, and Rm,,, were
still obtained by a weighted nonlinear least squares regression analysis, and
the parameter m was taken as the slope of the binding curve at high
concentrations of the phospholipid to compensate for the probability of
energy transfer associated with high acceptor concentrations. The value of
m was estimated both independently and then rigidly constrained as well as
simultaneously estimated along with the other parameters of the binding
interaction. It was found to be similar by both methods, and the binding
parameters were independent of the way the value of m was determined.
Global analysis of muftiple data sets
Global analysis of data was carried out using SCoP, the Simulation Control
Program (Simulation Resources, Berrien Spring, MI). Analysis was per-
formed on combinations of data sets simultaneously using the appropriate
binding equation for each type of experiment (Eqs. 3, 5, or 6). The
dissociation constant and the stoichiometry values were assigned as the
global variables (i.e., common to all sets of data), the Rm.. values were
local variables (i.e., different and individually estimated for each data set),
and m was constrained to the value obtained in individual fitting of the
energy transfer experiment. A multifit nonlinear least squares regression
analysis routine was constructed using the algorithms supplied in the SCoP
package and was then used to vary Kd, i, and Rmk to fit to the observed
data. SCoP uses its own principle axis algorithm for optimization of an
error function with respect to parameter values.
RESULTS
Binding of factor Va to DMPC vesicles monitored
using DPH fluorescence anisotropy
Fig. 1 records the effect of increasing concentration of
factor Va on the fluorescence anisotropy of DPH associated
with DMPC SUVs (15 ,LM) at 30°C. There was a gradual
increase in DPH anisotropy with increasing concentrations
of the protein, thus indicating an effect of factor Va on the
membrane due to binding. That the anisotropy effect was
not due to binding of the protein to DPH was established in
control experiments using DPH and factor Va without ves-
icles. Although DPH showed a slight increase in fluores-
cence intensity in the presence of factor Va, there was no
increase in its fluorescence anisotropy under these condi-
tions. Binding parameters were estimated from the titration
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Binding of factor Va to Rh-PE-labeled
POPC vesicles
The increase in fluorescence anisotropy of rhodamine in
Rh-PE-labeled POPC SUVs (200 ,tM) was monitored as a
function of increasing concentrations of factor Va (Fig. 2).
Because the rhodamine is attached directly to the head
group of the lipid, interactions of the protein with the
membrane surface apparently result in a change of rhodam-
ine's fluorescence anisotropy. We note that Rh-PE has a
negative charge and that the vesicles used in these experi-
ments contain a small amount (1%) of negatively charged
lipid. A negatively curved titration response suggestive of a
saturating behavior was observed. As in Fig. 1, saturation
was far from complete and rmax could not be estimated
directly from the titration curve, so it was adjusted to fit the
experimental data to Eq. 3. This analysis produced estimates
0.5 1.0 1.5 2.0 2.5 3.0
for the dissociation constant of 2.94 ,uM and stoichiometry
0.5 3.0 of 158 moles of phospholipid mole of factor Va.
[V] PM
FIGURE 1 Titration of DMPC vesicles with factor Va. Effect of increas-
ing concentrations of factor Va on the fluorescence anisotropy of DPH
partitioned into DMPC SUVs (15 ,uM). The probe-to-phospholipid ratio
was 1: 150. The titration was carried out at a temperature of 30°C. The solid
line represents simulation of the data with the binding parameters given in
Table 1. The dashed line represents a simulation done with binding
parameters obtained using the SCoP fitting routine to fit only this data set.
curve for the binding of factor Va to DMPC membranes as
described in Materials and Methods. The binding curve
shown in Fig. 1 does not attain complete saturation because
the concentration of factor Va required for reaching saturat-
ing values of anisotropy (rmaX) would be prohibitively high.
Therefore, the value of rma, had to be determined as an
adjustable parameter by fitting the data to Eq. 3. A disso-
ciation constant of 1.4 ,uM and a stoichiometry of 29
phospholipids per protein molecule were obtained using this
procedure, as summarized in Table 1.
Binding of fluorescein-labeled factor Va to POPC
and 25/75 bovine PS/POPC SUVs
Binding of factor Va to POPC vesicles was monitored by
measuring the change in fluorescence anisotropy of fluores-
cein-labeled factor Va (0.16 ,uM) with addition of increasing
concentrations of the neutral lipid vesicles (Fig. 3 A). The
binding of fluorescein-labeled factor Va (0.3 ,uM) to vesi-
cles composed of 25/75 bovine PS/POPC was also moni-
tored by this method as shown in Fig. 3 B. An increase in
anisotropy values was seen in both cases, and saturable
behavior was evident at high vesicle concentrations. As
expected, the concentration of phospholipid required for
reaching saturation values of anisotropy was much higher
for vesicles composed of only neutral phospholipid. The
values of rmax, dissociation constant, and stoichiometry
were obtained for the vesicles containing acidic phospho-
lipid using Eq. 5. Our fitting routine returned rmax = 0.24 +
0.0006, Kd = 3.7 + 1.3 nM, and a stoichiometry of 70 ± 2
phospholipids per site. These are in reasonable agreement
TABLE 1 Binding constants for factor Va binding to phosphatidyicholine membranes
Sample Titrant Technique Rmax Kd (M) Stoichiometry Rmax
DMPC-DPH SUVs
(15 /LM) Va Anisotropy rmax = 0.323 + 0.008 1.4e-6 ± 6.5e-8 29 ± 1
POPC:Rh-PE
SUVs (200 /.M) Va Anisotropy rmax = 0.282 + 0.010 2.94e-6 ± 7.6e-7 158 ± 74 0.2796 ± 0.015
Fluorescein-Va
(0.16 ,uM) POPC SUVs Anisotropy rmax 0.275 + 0.004 4.7e-9 + 6.2e-9 2051 ± 109 0.3295 ± 0.02
Fluorescein-Va
(0.33 IiM) POPC:Rh-PE-SUVs FET (520 nm) (Fd/Fda)max = 1.137 + 0.008 3.71e-6 ± 6.2e-5 102 + 1583 1.1585 + 0.016
Fluorescein-Va
(0.33 ,uM) POPC:Rh-PE-SUVs FET (590 nm) Fmax = 0497 + 0.009 0.12e-6 + 6.9e-8 1553 ± 255 0.5898 ± 0.036
Kd, stoichiometry, and Rm. values were determined independently for each experimental data set, as described in Materials and Methods. Uncertainties
in parameter values are given as asymptotic standard errors. Rm. values were obtained by a global fit of data sets 2-5 wherein the dissociation constant
Kd (3.0e-6 ± 0.22e-6 M) and the binding stoichiometry (200 ± 40) were global variables and the values of Rma,, were local variables. FET, fluorescein
energy transfer.
0.26 _
0.24 -
0.22 -
Of 0.20 :0
1 0.18 :
0
z 0.16 -
0.14 -
0.12
0.10
0.0
2933Koppaka and Lentz
Volume 70 June 1996
0.24
0.22
0.20
0
I- 0.18
0
Z 0.16
0.14_
0.12
0 1 2 3 4 5 6 7 8
[Va] pM
FIGURE 2 Titration of POPC vesicles with factor Va. Effect of increas-
ing concentrations of factor Va on the rhodamine fluorescence anisotropy
of Rh-PE/POPC (1/99) SUVs at a lipid concentration of 200 ,LM. The
experiment was carried out at 23°C. The solid line represents simulation of
the data with the binding parameters given in Table 1. The dashed line
represents a simulation done with binding parameters obtained using the
SCoP fitting routine to fit globally experiments 2-5 (Table 1).
with values obtained elsewhere (2.72 nM ± 0.47, 42; Krish-
naswamy and Mann, 1988) and in our earlier study (1.3
nM ± 0.28, 43; Cutsforth et al., 1996) using a pyrene-
labeled factor Va. A similar treatment of the anisotropy data
for binding of factor Va to POPC vesicles yielded a disso-
ciation constant in the nanomolar range along with a very
large value for the stoichiometry of -2000 phospholipids
per factor Va binding site (Table 1). Although these results
agree with our other measurements in showing a factor-Va-
neutral lipid interaction, these binding parameters are not at
all in reasonable agreement with the values from the other
two experiments reported in Table 1, a problem that will be
discussed below.
Binding of factor Va to POPC vesicles using
fluorescence energy transfer
Finally, binding of factor Va to POPC/Rh-PE (99/1) SUVs
was also monitored using fluorescence energy transfer from
fluorescein-labeled factor Va and rhodamine-labeled phos-
phatidylethanolamine. Fluorescein and rhodamine form an
efficient fluorescence donor-acceptor pair. Fig. 4 shows the
decrease in fluorescence intensity of fluorescein-labeled
factor Va (monitored at 520 nm) as a result of energy
transfer to rhodamine-labeled phospholipid with increasing
concentration of the POPC/Rh-PE vesicles. It is evident
from these studies, as from our other results, that factor Va
0.30
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FIGURE 3 Titration of fluorescein-labeled factor Va with phospholipid
vesicles. (A) Effect of increasing concentrations of POPC SUVs on the
fluorescence anisotropy of fluorescein-labeled factor Va. (B) Effect of
increasing concentrations of bovine PS/POPC (25/75) SUVs on fluores-
cence anisotropy of fluorescein-labeled factor Va. The initial concentration
of Va was 0.16 ,uM in A and 0.3 ,uM in B in 20 mM TES, 150 mM NaCl,
5 mM CaC12, pH 7.5. The solid and dashed lines were obtained as in Fig.
2.
interacts with vesicles containing only neutral lipid mole-
cules. However, a clear saturation was not evident even at
very high concentrations of added vesicles. Instead, the
quenching of donor fluorescence became linear at very high
acceptor concentration, consistent with what we would ex-
pect for a donor/acceptor pair in solution rather than inter-
acting by forming a complex. Binding parameters were
therefore estimated from the data as described in Materials
and Methods using Eq. 6, which includes a term for this
solution phase contribution to energy transfer. The binding
parameters obtained (Table 1; Kd of -3.7 AM; stoichiom-
etry of 102 moles of lipid monomers per mole of binding
site) were not inconsistent with the results from our first two
experiments. However, the large errors in the estimated
values for these parameters indicate that they could not be
determined uniquely from this experiment alone.
It is possible to analyze energy transfer data by monitor-
ing the increase in acceptor fluorescence rather than the
decrease in donor fluorescence, as was done in Fig. 4. The
increase in fluorescence intensity (monitored at 590 nm) of
rhodamine-labeled phospholipid due to energy transfer from
fluorescein-labeled factor Va is shown in Fig. 5. Because of
some overlap in the excitation spectra of fluorescein and
A
SZ,... .. . . .. . .. . .
. . . I .
U.zz IF .............. I.... I.... I.... .... I...W d-d- -
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FIGURE 4 Fluorescein-rhodamine energy transfer quenching of fluores-
cein-labeled factor Va by Rh-PE. The quenching of fluorescein-labeled
factor Va fluorescence (0.33 ,uM in 20 mM TES, 150 mM NaCl, 5 mM
CaCl2, pH 7.5) at 520 nm was monitored as a function of increasing
concentrations of Rh-PE/POPC (1/99) SUVs. Fd and Fda are the fluores-
cence intensities of fluorescein-Va in the absence and presence of the
Rh-PE acceptor. The solid and dashed lines were obtained as in Fig. 2.
rhodamine, a parallel experiment was performed in which
the fluorescence of increasing concentrations of rhodamine-
labeled phospholipid alone was monitored, and this linear
response was subtracted from the data obtained with a
donor-acceptor mixture. Data were fitted using Eq. 5 to
yield estimates of all three parameters; these are given in
Table 1. We note once again that the data confirm that
binding occurs but yield a smaller dissociation constant (Kd
= 0.1 ,uM) and larger stoichiometry (1553 lipids per site)
than three of our five experiments.
DISCUSSION
Information content of
membrane-binding experiments
Our results make it clear that factor Va binds weakly to
neutral lipid membranes, although the interaction is so
weak, as compared with its binding to membranes contain-
ing acidic phospholipids, that it is difficult to obtain a
clearly defined estimate of the binding parameters under
practical experimental conditions. We have seen that fitting
the experimentally obtained binding isotherms to Eqs. 3 or
5 yielded values for Kd and the stoichiometry that were
linked, i.e., lower than expected Kd values were paired with
higher than expected stoichiometries. This can lead to very
large uncertainties in one or more fitting parameters (Table
1). We have noted a similar ambiguity in and linkage
between the parameters describing the weak binding of
factor Va to membranes containing low concentrations of
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FIGURE 5 Enhancement of Rh-PE fluorescence due fluorescein-rho-
damine energy transfer from fluorescein-labeled factor Va. The increase in
fluorescence intensity of rhodamine at 590 nm due to fluorescence energy
transfer from fluorescein-labeled factor Va (0.33 ,uM in 20 mM TES, 150
mM NaCl, 5 mM CaCl2, pH 7.5) is plotted as a function of increasing
concentrations of Rh-PE/POPC (1/99) SUVs. The solid and dashed lines
were obtained as in Fig. 2.
acidic lipids (Cutsforth et al., 1996). It is worth commenting
on the origin of this ambiguity.
Descriptions of experimental binding curves in terms of
the Langmuir adsorption model are defined by three param-
eters, Kd, i, and Rma. Kd/i is essentially determined by the
curvature of the titration curve, which is why these two
parameters are generally tightly coupled. However, the cur-
vature is also strongly influenced by how well the saturation
is defined (i.e., by the value of Rmax). Even if the curvature
and the saturation of the curve are well defined, this does
not guarantee a unique definition of all three parameters.
Another piece of information that can provide a constraint
leading to a unique definition of all three parameters is the
conversion constant that relates the response observed per
molar concentration of sites occupied:
SR 6R
k'- *~[-p-]; k 6-P[Pb B[PL]b (7)
where k' and k are the respective conversion constants
relevant to the first and second types of experiments we
have described. If we focus now on the second type of
experiment (addition of lipid vesicles to a fixed amount of
protein), the fundamental assumption [PI/[P]T = (R -
Ro)/(Rn,a - Ro) can be rearranged to give
(Rma - Ro) = k
[P]T ~~~~~~(8)
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A similar equation can be obtained for the first type of
experiment we considered, namely, adding protein to a
fixed concentration of lipid vesicles:
(R -R) = k' i (9)
These equations relate Rm. and i, two of the three param-
eters needed to describe the binding isotherms generated by
the two types of experiments considered here. If k is known,
then, we have an additional constraint on the set of param-
eter values that can be used to describe a given data set.
Now, we describe how these comments apply to the data
sets under consideration here. If the experiment is set up such
that the site concentration is high, i.e., [PL]Ti, Kd (first type of
experiment) or []T > Kd (second typ of experiment), the
great majority of initially added ligand (protein or lipid) will
bind to the lipid or protein sites initially available. Under these
conditions, we have an estimate of k, namely, as provided by
the initial slope ofR versus ]T or [PLIT, and Eqs. 8 and 9 can
provide useful constraints on the possible range of RII,. and i
values allowed for the data. If the site concentration condition
and clear saturation are achieved (an ideal experiment), only
Kd need be defined and the binding data can be defined
unambiguously in terms of empirical Langmuir constants.
Such is the case for factor Va binding at high acidic lipid
content (Cutsforth et al., 1996). It is, however, very difficult to
even approach these ideal experimental conditions for studying
the weak binding of factor Va to neutral phospholipid mem-
branes, as one would require very large quantities of factor Va
(>5 `M). If the value of aR/a[PL]b is poorly defined, it is still
possible to obtain unique parameters if saturation is finnly
established. Such is not the case for the weak binding events
defined here. We note, however, that the two types of exper-
iments performed here have inverse constraining relationships
between i and Rm. (Eqs. 8 and 9). This raises the expectation
that simultaneous or global fitting of data from both types of
experiments can constrain i to a more narrow range of possible
values. In the next section, we describe how we have used
information from multiple data sets to obtain a stable estimate
of binding parameters.
Global estimation of binding parameters
To overcome the problem outlined above, the data from
both types of experiments (2-5 in Table 1) were fitted
globally as described in Materials and Methods. A Kd value
of 3.0 ± 0.22 ,uM and a stoichiometry value of 200 ± 40
was obtained along with the individual values for Rm.
(Table 1). Unlike fits to individual data sets, this global fit
was stable, that is, different initial estimates of parameter
values led to the same best fit parameters. The global fits of
the data are shown as dashed lines in Figs. 2-5, with the
values for Rmax summarized in Table 1. These reveal that
descriptions of all four data sets can be obtained with one
value for Kd (3.0 ,uM) and one stoichiometry (200). The
reflect the curvature of the residual space defined by the
four particular data sets that were fit. The use of asymptotic
standard errors by the SCoP routine make it likely that these
standard deviations underestimate the actual uncertainties in
these parameters, which could probably only be estimated
rigorously by repeating our measurements and global anal-
ysis seven or more times, an impractical undertaking. We
can say from our results only that factor Va binds to neutral
lipid membranes with a dissociation constant of approxi-
mately 3.0 ,uM (probably 2-6) and a stoichiometry of
approximately 200 (probably 100-400) moles of phospho-
lipid monomer per mole of Va. Additional uncertainty arises
from the fact that, in three of these experiments (2, 4, and 5
in Table 1) we have used 1% of a charged, labeled lipid
(Rh-PE). However, experiments 1 and 3 avoid this compli-
cation and can be described by comparable binding param-
eters, suggesting that the negative charge on Rh-PE does not
greatly influence our results.
Attempts to include the data from Fig. 1 (experiment 1,
binding of factor Va to DMPC vesicles monitored using
DPH fluorescence anisotropy) in the global analysis failed
to give a good fit to this data set and returned unreasonable
values of RmaX (>0.4). This data set could be fit individually
with the same least squares routine used for the global
analysis (dashed curve in Fig. 1), giving binding parameters
(Kd = 1.8 ± 0.3 ,uM; stoichiometry of 200 ± 80; and rm.
= 0.344 ± 0.022) in agreement (except for the stoichiom-
etry) with the binding parameters summarized in Table 1.
We suspect that binding at 30°C to DMPC (a saturated
phospholipid) SUVs may involve a somewhat smaller Kd
than does binding at 23°C to POPC (an unsaturated phos-
pholipid) SUVs, although more experiments would be
needed to confirm this.
Relationship to other results
Several reports have presented evidence that membrane bind-
ing of factor Va involves two types of interactions of the factor
Va light chain with acidic-lipid-containing membranes, a hy-
drophobic and an electrostatics-based interaction (Lecompte et
al., 1987, 1994; Kalafatis et al., 1990; Ortel et al., 1992). Also,
factor Va light chain was labeled by 1-azidopyrene, a lipophilic
photoactivatable probe, more readily in the presence of PC
membranes than in their absence (Kalafatis et al., 1994). Our
analysis of the equilibrium binding of pyrene-labeled bovine
factor Va to membranes composed of different mixtures of
bovine PS witliPOPC have suggested also that one component
of the binding involves a significant PS-independent interac-
tion, whereas another component may involve a few sites that
recognize acidic phospholipids, perhaps even with some spec-
ificity for PS (Cutsforth et al., 1996). These results implied an
interaction with pure PC membranes, although we and others
were unable to demonstrate this with pyrene factor Va
(Cutsforti et al., 1996; Krishnaswamy and Mann, 1988). All of
these results suggest that factor Va binding to neutral lipid
membranes should be detectable, as we report here that it is.
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To our knowledge, the data presented here provide the first
direct evidence that factor Va binds to neutral lipid membranes.
Given that this binding has not been reported previously, the
estimated Kd implies a surprisingly strong interaction. Based
on the estimated Kd, the standard free energy of binding is
-7.2 kcallmol. As the cratic contribution to this free energy
change (estimated using a classical translational partition func-
tion of a particle in a box as the entropy change associated with
moving factor Va from a large volume in solution to a mole-
cule-sized volume on the membrane surface) is approximately
4 kcal/mol, the unitary free energy of binding (due to other
than entropy changes related to changes in volumes occupied)
is estimated as -11 kcai/mol (Kauzmann, 1959), which com-
pares to approximately -16 kcal/mol for binding to acidic-
lipid-rich membranes (Cutsforth et al., 1996). From these es-
timates, it is seen that the acidic-lipid-independent contribution
to the unitary free energy of the factor Va-membrane interac-
tion is substantial.
It has been reported previously that PC membranes en-
hance the rate of prothrombin activation by factor Xa in the
presence of factor Va but not in its absence (Gerads et al.,
1990; Govers-Riemslag et al., 1994). The dependence of
rate on factor Xa concentration suggested an effective as-
sembly constant of 100 nM at physiological ionic strength
(Govers-Riemslag et al., 1994). This is somewhat tighter
than the interaction seen here for factor Va alone, although
it may be that factor Xa contributes in some way to the
assembly constant. Our analysis of factor Va binding has
suggested an acidic-lipid-independent binding with a disso-
ciation constant (Kd) in the 100 ,uM range (Cutsforth et al.,
1996). However, this estimate derives from studies of bind-
ing in membranes containing low amounts of acidic lipids,
and a conclusion of this study was that the acidic-lipid-
dependent and acidic-lipid-independent sites on factor Va
were not independent, i.e., occupancy of acidic-lipid-depen-
dent sites decreased the strength of the acidic-lipid-indepen-
dent interaction. Our observation of the -3.0 ,uM dissoci-
ation constant for factor Va interaction with pure PC
membranes is consistent with this view. Consistent with the
possibility that occupancy of acidic lipid sites somehow
alters factor Va and its acidic-lipid-independent interaction
with membranes is the observation that the rm. value for
fluorescein-Va was different for binding to PC versus PS/
POPC membranes (Fig. 3). This dependence of rmax on
acidic lipid content was also seen with pyrene-factor Va
(Cutsforth et al., 1996).
We thank the reviewers for suggesting the global analysis of our binding
data.
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